Therapeutic targeting of respiratory syncytial virus G-protein.
about
Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease PathogenesisEffects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infectionProphylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c mice.A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell typesAn anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice.A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice.Identifying targets in the hunt for effective respiratory syncytial virus interventions.Advances in and the potential of vaccines for respiratory syncytial virus.A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.Human Respiratory Syncytial Virus: An Introduction.Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses.
P2860
Q26823449-067E7F77-2729-4C0B-A1D1-3D983FB242C7Q33881536-D8D0133B-3CC2-419C-865B-A43BFB34D9BFQ34262180-8C2C441E-7208-47DF-A241-3ED239C4C6C1Q34540179-DD2649DD-E775-4D85-B46F-5753E251C617Q35076970-149847CD-1FA2-4D79-A228-8B0BBA601DA2Q35893983-B69B0745-1D77-4BB0-91FE-1238BCD148C0Q37252613-5E83C41F-FF4F-4F90-BA00-9667AE574067Q37997822-0F21D982-3251-4993-BA7D-6B52CCECCCBFQ38130514-9BED6308-C024-440A-8AE5-856A4C69B598Q38905050-A30439BD-6BF0-4DE0-BC48-4EB4B2B2FD98Q40597806-7BA8FA8E-352E-4986-88DD-BF9C6587732BQ41838015-59C615A0-F479-41B8-A35E-A4CDE9985543
P2860
Therapeutic targeting of respiratory syncytial virus G-protein.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Therapeutic targeting of respiratory syncytial virus G-protein.
@ast
Therapeutic targeting of respiratory syncytial virus G-protein.
@en
Therapeutic targeting of respiratory syncytial virus G-protein.
@nl
type
label
Therapeutic targeting of respiratory syncytial virus G-protein.
@ast
Therapeutic targeting of respiratory syncytial virus G-protein.
@en
Therapeutic targeting of respiratory syncytial virus G-protein.
@nl
prefLabel
Therapeutic targeting of respiratory syncytial virus G-protein.
@ast
Therapeutic targeting of respiratory syncytial virus G-protein.
@en
Therapeutic targeting of respiratory syncytial virus G-protein.
@nl
P2093
P2860
P356
P1433
P1476
Therapeutic targeting of respiratory syncytial virus G-protein
@en
P2093
Jennifer L Harcourt
Lawrence M Kauvar
Lia M Haynes
P2860
P304
P356
10.2217/IMT.10.53
P577
2010-09-01T00:00:00Z